Home
Conferences
Events
Media
Publications
Resources
NCCN
ASCO
Hematology
Sign In
Home
Conferences
Events
Media
Publications
Resources
Search
Home
Conferences
Events
Media
Publications
Resources
NCCN
ASCO
Hematology
Trending →
T-DXd Plus Pertuzumab Receives FDA Approval, Shifting the Frontline HER2-Positive Paradigm
By
MedOnc2
December 15, 2025
FDA Approves Niraparib Plus Abiraterone Acetate and Prednisone for BRCA2-Mutated mCSPC
By
MedOnc2
December 15, 2025
FDA Approves Durvalumab for Resectable Gastric and Gastroesophageal Junction Adenocarcinoma
By
MedOnc2
December 15, 2025
FDA Grants Traditional Approval to Pirtobrutinib (Jaypirca®) for CLL/SLL
By
MedOnc2
December 15, 2025
Enfortumab Vedotin + Pembrolizumab for Muscle-Invasive Bladder Cancer (MIBC)
By
MedOnc2
November 22, 2025
Login
Sign In
Follow US
Oops! Nothing here
It seems we can’t find what you’re looking for. Perhaps searching can help.
Search for:
Return to Homepage